Translational Oncology

SJR Rank #2,820H-index: 84SJR: 1.383Best quartile: Q1Open AccessAPC: US$3,390Listed in DOAJ

Journal website: aims, scope and author guidelines

Publisher

Neoplasia Press, Inc.

Country

United States

Type

journal

SJR by Edition

Subject Categories

OncologyQ1
Cancer ResearchQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Ferroptosis and cancer prognosisCancer Immunotherapy and BiomarkersCancer Cells and MetastasisCancer, Hypoxia, and MetabolismCancer-related molecular mechanisms researchRNA modifications and cancerMicroRNA in disease regulationCancer Genomics and DiagnosticsImmune cells in cancerImmunotherapy and Immune Responses

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

1944-7124, 1936-5233

SJR Best Quartile

Region

Northern America

Citations per Document (2 years)

5.03

References per Document

53.94

Coverage

2008-2026

Scope

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

Metrics from SCImago Journal Rank 2025. View on SCImago